[Perspective of calcium antagonist]
- PMID: 15632476
[Perspective of calcium antagonist]
Abstract
L-type calcium channel antagonist is clinically used for treatment of cardiovascular diseases such as angina, hypertension and arrhythmia. Recent large clinical trials indicated that calcium antagonist is effective in the prevention of cardiovascular event as well as the treatment of hypertension. Recently, calcium antagonists, not stimulating sympathetic nerve activity, have been newly developed. In the future, clinical application of N-type or T-type calcium antagonist are expected.
Similar articles
-
[Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].Clin Calcium. 2010 Jan;20(1):24-30. Clin Calcium. 2010. PMID: 20048430 Review. Japanese.
-
Calcium antagonists and sympathetic nerve activation: are there differences between classes?J Hypertens Suppl. 1998 Jan;16(1):S17-24. J Hypertens Suppl. 1998. PMID: 9534092 Review.
-
Ca2+ channel subtypes and pharmacology in the kidney.Circ Res. 2007 Feb 16;100(3):342-53. doi: 10.1161/01.RES.0000256155.31133.49. Circ Res. 2007. PMID: 17307972 Review.
-
[Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].Clin Calcium. 2004 Jan;14(1):119-27. Clin Calcium. 2004. PMID: 15576967 Review. Japanese.
-
[Bone and calcium update; research of calcium metabolism on cardiovascular system update. Calcium channel blocker update].Clin Calcium. 2011 Dec;21(12):34-42. Clin Calcium. 2011. PMID: 22133822 Review. Japanese.